You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Momentum for Poolbeg and CytoReason’s AI collaboration

Poolbeg Pharma – a company concentrating on infectious conditions with a high unmet medical need – has announced a notable breakthrough in its world-first influenza artificial intelligence (AI) programme with CytoReason.